基于GWAS汇总统计量的表观全基因组关联研究和转录组整合分析
Epigenome-wide association study and integrative analysis with the transcriptome based on GWAS summary statistics
摘要:
在过去的十年中,组学技术迅速发展。全基因组关联研究(GWAS)发现了多种复杂性状的易感性变异。然而,大多数发现的变体的功能意义仍然没有完全理解。另一方面,人们对探索表观遗传变异如DNA甲基化在疾病发病机制中的作用越来越感兴趣。在这项工作中,我们提出了一个总体框架,表观基因组关联研究和整合分析与转录组的基础上GWAS汇总统计和数据的甲基化和表达数量性状基因座(QTL)的研究。该框架是基于孟德尔随机化,这是更不容易受到混淆和反向因果关系相比,传统的研究。该框架应用于五种复杂疾病。我们首先确定了由于遗传变异而差异甲基化的基因座,然后开发了几种方法用于与GWAS估算的转录组进行联合测试。我们发现了许多新的候选基因,这些基因在最初的GWAS研究中没有涉及。我们还观察到强有力的证据(最低p = 2.01e-184),在甲基化基因座定位的顶级基因之间的差异表达。这里提出的框架开辟了一种新的方式来分析GWAS摘要数据,并将有助于更深入地了解疾病的机制。
英文摘要:
The past decade has seen a rapid growth in omics technologies. Genome-wide association studies (GWAS) have uncovered susceptibility variants for a variety of complex traits. However, the functional significance of most discovered variants are still not fully understood. On the other hand, there is increasing interest in exploring the role of epigenetic variations such as DNA methylation in disease pathogenesis. In this work, we present a general framework for epigenome-wide association study and integrative analysis with the transcriptome based on GWAS summary statistics and data from methylation and expression quantitative trait loci (QTL) studies. The framework is based on Mendelian randomization, which is much less vulnerable to confounding and reverse causation compared to conventional studies. The framework was applied to five complex diseases. We first identified loci that are differentially methylated due to genetic variations, and then developed several approaches for joint testing with the GWAS-imputed transcriptome. We discovered a number of novel candidate genes that are not implicated in the original GWAS studies. We also observed strong evidence (lowest p = 2.01e-184) for differential expression among the top genes mapped to methylation loci. The framework proposed here opens a new way of analyzing GWAS summary data and will be useful for gaining deeper insight into disease mechanisms.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。